🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective is to determine if the medication Carbamazepine, can ...
Status
Terminated
Location
Washington University in St. Louis School of Medicine
Start Date
2012-01
Trial ID
NCT01379469
Treatments Being Tested
Study N01175 was to compare overall effectiveness (efficacy and safety) of ...
Status
Completed
Location
Multiple Locations
Start Date
2005-02
Trial ID
NCT00175903
Treatments Being Tested
To examine the safety and effectiveness of extended-release carbamazepine i...
Status
Completed
Location
11 Shire Clinical Research Site
Start Date
2006-07
Trial ID
NCT00350857
Treatments Being Tested
Researchers have designed a study medicine called opevesostat as a new way ...
Status
Completed
Location
Celerion ( Site 0001)
Start Date
2024-12-18
Trial ID
NCT06633419
Treatments Being Tested
To study the efficacy and safety of beaded extended-release Carbamazepine (...
Status
Completed
Location
Tuscaloosa Research and Education Advancement Corporation
Start Date
2005-08
Trial ID
NCT00203567
Treatments Being Tested
The purpose of this study is to compare the efficacy and safety of SPD417 i...
Status
Completed
Location
Multiple Locations
Start Date
2005-01
Trial ID
NCT00150553
Treatments Being Tested
The main objective of this trial is to investigate the effect of multiple o...
Status
Completed
Location
CRS Clinical Research Services Mannheim GmbH
Start Date
2023-09-11
Trial ID
NCT06028464
Treatments Being Tested
The purpose of this study is to evaluate the safety of SPD417 when given wi...
Status
Completed
Location
Multiple Locations
Start Date
2005-02
Trial ID
NCT00150605
Treatments Being Tested
Researchers have designed a study medicine called bomedemstat (MK-3543) as ...
Status
Completed
Location
Celerion, Inc. ( Site 0001)
Start Date
2024-10-02
Trial ID
NCT06596668
Treatments Being Tested